Did you know? We're now the sole specialty pharmacy provider for Danziten™.

Biologics by McKesson is our specialty #pharmacy business that specializes in #cancer and rare disease areas. We have What it Takes to deliver personalized care so patients understand how to take medications and achieve the best possible outcomes. Learn more: bit.ly/4aZgzVS

Proud to announce that we are now a pharmacy for Romvimza (vimseltinib), an approved for treatment for #TGCT. We're excited to work with Deciphera Pharma to help improve quality of life for patients by getting them this treatment. Find out more here: bit.ly/4b2NKIa

Excited to be chosen by @springworkstx as a distributor of GOMEKLI™ (mirdametinib)! We're grateful for the opportunity to help improve the lives of patients with NF1-PN. Find out more: biologics.mckesson.com/gomekli-mirdam… #RareDisease #Neurofibromatosis #PatientCenteredCare

Proud to announce that we have been chosen to dispense VANRAFIA™ (atrasentan). This drug can improve #IgAN patients' quality of life. Find out more: biologics.mckesson.com/vanrafia-atras… #DrugLaunch

Good news! We now dispense AVMAPKI™ FAKZYNJA™ CO-PACK (avutometinib capsules; defactinib tablets). These drugs work together to treat KRAS-mutated recurrent #LGSOC. We're proud to help patients get the treatments they need. Find out more: biologics.mckesson.com/avmapki-fakzyn…

Excited to be chosen by AbbVie to dispense EMRELIS™ (telisotuzumab vedotin-tllv). This therapy can be used to treat adult patients with certain kinds of non-small cell lung cancer (#NSCLC). Find out more here: biologics.mckesson.com/emrelis-teliso… #LungCancer #SpecialtyPharmacy

Good news! We've been chosen by Nuvation Bio to dispense IBTROZI™ (taletrectinib). Find out more: biologics.mckesson.com/ibtrozi-taletr…

This just in! We've been chosen by BMS to dispense AUGTYRO™ (repotrectinib) as part of a new limited distribution network. Learn more: biologics.mckesson.com/augtyro-repotr…

Good news! We have been chosen by Xcovery Holdings, Inc. to be the sole specialty pharmacy provider for ENSACOVE™ (ensartinib). This drug treats adult patients with advanced ALK-positive #NSCLC. Find out more: biologics.mckesson.com/ensacove-ensar… #SpecialtyPharmacy #LungCancer

Proud to be the exclusive specialty pharmacy for PIQRAY® (alpelisib). This drug helps treat adults certain kinds of breast cancer involving PIK3CA mutations. We're glad to be able to support these patients. Find out more: biologics.mckesson.com/piqray-alpelis… #BreastCancer

This just in! We've been chosen by Amgen 🧪🔬🧬 to dispense TAVNEOS® (avacopan) as part of a new limited distribution network. This drug treats ANC-associated vasculitis. See our full drug list here: biologics.mckesson.com/specialty-drug… #Vasculitis #CancerTreatment #CancerCare

Excited to announce that we are now the exclusive #SpecialtyPharmacy for VIJOICE® (alpelisib). This drug treats adults and children over 2 years old with #PROS. We're proud to help patients improve their quality of life with this drug! Find out more: biologics.mckesson.com/vijoice-alpeli…

Meet Biologics by McKesson, a specialty pharmacy leader that creates extraordinary experiences for oncology, cell and gene, and rare disease patients and a NASP Corporate Member of the Month! Learn more: bit.ly/3UEzNJ8 #SpecialtyPharmacy #ThisIsNASP

We're pleased to offer WAYRILZ™ (rilzabrutinib) as part of Sanofi's limited distribution network. This drug is used to treat #ITP. We're honored to help get this treatment to those who need it. Learn more here: biologics.mckesson.com/wayrilz-rilzab… #DrugLaunch #AutoimmuneDisorders

Proud to be chosen by Crinetics Pharmaceuticals to distribute PALSONIFY™ (paltusotine) as part of a limited distribution network. Find out more: PALSONIFY.com #DrugLaunch #HealthcareInnovation #Acromegaly

We’re proud to have been selected by Eli Lilly and Company to distribute Inluriyo™ (imlunestrant), a newly FDA-approved oral therapy for ER+, HER2–, ESR1-mutated #MetastaticBreastCancer. Learn more: biologics.mckesson.com/inluriyo-imlun… #DrugLaunch

#AML comes with many long-term challenges. But today, there's new hope: We're proud to announce that we've been chosen by Kura Oncology to be a limited specialty pharmacy provider for KOMZIFTI® (ziftomenib). Learn more: biologics.mckesson.com/komzifti-zifto… #Leukemia #Ziftomenib

Proud to be the exclusive specialty pharmacy provider for AQVESME® (mitapivat), developed by Agios. This treatment is approved for adults with #Thalassemia and offers a safer, less invasive option. We're honored to support the patients who need it. biologics.mckesson.com/aqvesme-mitapi…

Our Pharmacy Elite™ program has been chosen as Rigel Pharmaceuticals’s hub services provider for their important therapies: TAVALISSE, GAVRETO and REZLIDHIA. Patients' treatment journeys just got easier! biologics.mckesson.com/biologics-by-m… #PatientSupportServices